Drug Database
Back to search

Netherlands· NL-852fc8626189

Silodyx 8mg, harde capsules

A prazosin product containing silodosine, registered in Netherlands by Recordati Ireland Ltd. (Co. Cork). The same ATC class is registered in 9 of our 19 countries.

ATC C02CA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSilodyx 8mg, harde capsulesATCC02CA01REGISTER NO.NL-852fc8626189PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about silodosineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Prazosin is registered in 9 of 19 countries.

Countries holding a registration under ATC C02CA01 (prazosin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search prazosin products by name

Prazosin · ATC C02CA01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SILODOSINE
Manufacturer
Recordati Ireland Ltd. (Co. Cork)
Country
Netherlands (NL)
ATC code
C02CA01
ATC class
Prazosin
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/09/607

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

98 interactions on record for prazosin.

Graded by severity as the source publishes them — 78 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check prazosin against other medicinesHow interaction checks work

Prazosin · interactions on record

98 records

  • 78 moderate
  • 20 info

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Prazosin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prazosin products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Belgium · Silodosin Ab
  • Bulgaria · Пирсео, Сидарсо
  • Germany · Silbesan, Silodosin Al
  • Spain · Silodosina Abamed, Silodosina Alter
  • France · Silodosine Arrow, Silodosine Biogaran
  • Croatia · Niksol, Sidarso
  • Hungary · Pirseo, Sidarso
  • Iceland · Silodosin Recordati, Silodyx
  • Italy · Silodosina Aristo, Silodosina Aurobindo
  • Liechtenstein · Silodosin Recordati, Silodyx
  • Lithuania · Sidarso
  • Norway · Silodosin Recordati, Silodyx
  • Poland · Sidarso, Silodosin Aurovitas
  • Portugal · Silodosin Ipca, Silodosin Msn
  • Romania · Sidarso
  • Slovenia · Sidarso
  • Slovakia · Sidarso, Silodosin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dcc02a20-88bf-4a8b-b3a0-e26e7ae65ee3
GET /v1/drugs/dcc02a20-88bf-4a8b-b3a0-e26e7ae65ee3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/silodyx-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Prazosin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp105963",
  "excipients": [
    "GELATINE (E 441)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "SILODOSINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2010/01/29",
  "procedure_number": "EMEA/H/C/001209",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/09/607",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about prazosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console